Clinical expression of 'silent' hepatitis B virus infection in a patient with visceral leishmaniasis

Infection. 2001 May-Jun;29(3):166-9. doi: 10.1007/s15010-001-1060-7.

Abstract

A 69-year-old male was hospitalized in January 1999 because of visceral leishmaniasis. He had also suffered from anti-hepatitis C virus (HCV)-positive chronic hepatitis for years. All serum hepatitis B virus (HBV) antigens and antibodies were negative except for anti-HBc. The patient was treated with amphotericin B cholesteryl sulfate (2 mg/kg twice a day for 7 days, iv). Fever disappeared on the 3rd day of treatment, the clinical condition improved rapidly and the patient recovered. In May 1999 the patient developed icteric HBsAg-negative acute hepatitis (aspartate aminotransferase 722 U/l; alanine aminotransferase 988 U/l). Anti-HBc IgM was positive and HBV-DNA was detected in serum by PCR. Anti-HAV IgM was negative. A serum sample obtained on presentation and stored at -80 degrees C was retrospectively tested and found positive for HBV-DNA. In July 1999, complete remission of acute hepatitis and seroconversion to anti-HBs was observed. We suppose that a moderate depression of the immune system, probably associated with leishmaniasis, may have enhanced HBV replication in the patient who had an HBsAg-negative 'silent' HBV infection. Restoration of the immune system after successful antiprotozoan therapy might have induced cell-mediated necrosis of the HBV-infected hepatocytes and seroconversion to anti-HBs.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • DNA, Viral / analysis
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / pathology*
  • Hepatocytes
  • Humans
  • Immunocompromised Host
  • Immunoglobulin M / analysis
  • Leishmaniasis, Visceral / complications*
  • Leishmaniasis, Visceral / immunology
  • Male
  • Necrosis
  • Polymerase Chain Reaction
  • Serologic Tests

Substances

  • Antiprotozoal Agents
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Immunoglobulin M
  • Amphotericin B